¾È°ú¿ë ±â±â ½ÃÀå : ¼¼°è ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®, ±âȸ, ¿¹Ãø(2019-2030³â)
Ophthalmological Devices Market - Global Size, Share, Trend Analysis, Opportunity and Forecast, 2019-2030, Segmented By Devices; By End User; By Region
»óǰÄÚµå
:
1534364
¸®¼Ä¡»ç
:
Blueweave Consulting & Research Private Limited
¹ßÇàÀÏ
:
2024³â 07¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 200 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± º¸°í¼¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¼¼°è ¾È°ú¿ë ±â±â ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 570¾ï ´Þ·¯·Î È®´ëµÉ Àü¸Á
¼¼°è ¾È°ú¿ë ±â±â ½ÃÀåÀº ¾ÈÁúȯ À¯º´·ü Áõ°¡, ±Þ¼ÓÇÑ °í·ÉÈ, ´« °Ç°¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ȣȲÀ» ´©¸®°í ÀÖ½À´Ï´Ù.
Àü·« ÄÁ¼³ÆÃ ¹× ½ÃÀå Á¶»ç Àü¹® ±â¾÷ BlueWeave ConsultingÀº ÃÖ±Ù Á¶»ç¿¡¼ 2023³â ¼¼°è ¾È°ú¿ë ±â±â ½ÃÀå ±Ô¸ð¸¦ ±Ý¾× ±âÁØÀ¸·Î 412¾ï ´Þ·¯·Î Ãß»êÇß½À´Ï´Ù. BlueWeave´Â 2024³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ¼¼°è ¾È°ú¿ë ±â±â ½ÃÀå ±Ô¸ð°¡ ¿¬Æò±Õ 4.80% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 570¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ±â¼ú ¹ßÀü, ½ÅÈï±¹ÀÇ ±â±â ¼ö¿ä Áõ°¡, ´« °Ç°¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡´Â ¾È°ú¿ë ±â±â ¼¼°è ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀÔ´Ï´Ù. ½ÅÈï±¹ÀÇ °¡Ã³ºÐ ¼Òµæ Áõ°¡¿Í ÀÇ·á ÀÎÇÁ¶ó °³¼±Àº ½ÃÀå ±â¾÷µé¿¡°Ô ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÁÖ¿ä Àü·«À¸·Î´Â ½ÅÁ¦Ç° Ãâ½Ã, »ç¾÷ È®Àå, Àμö, Á¦ÈÞ, ¼¼Æ÷ ±â¹Ý Ä¡·á µîÀÌ ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ À¯ÈÈíÀÔ¼ú ¹× ·¹ÀÌÀú º¸Á¶ ¼ö¼ú°ú °°Àº ¾È°ú ¼ö¼úÀÇ ¹ßÀüÀ¸·Î Ä¡·á È¿°ú¿Í ½Ã·Â ¿¹¹æÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù.
±âȸ - Çõ½ÅÀû ±â¼ú µµÀÔ È®´ë
Àü ¼¼°è ¾È°ú¿ë ±â±â ½ÃÀåÀº ½Å°æ ÀÌ½Ä Ä¡·á, »ýü°øÇÐ °¢¸·, Àΰø°¢¸·, ¸Á¸· À̽Ä, ¾È±¸°ÇÁ¶Áõ °¨Áö, Àΰø¼öÁ¤Ã¼, ÄÜÅÃÆ®·»Áî, ·¹ÀÌÀú µîÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿þ¾î·¯ºí AR/VR °í±Û, AI ±â¹Ý Ä¡·á¹ý, ¹ÙÀÌ¿À¼¾¼´Â ¾È°ú °Ë»ç ¹× ¸ð´ÏÅ͸µÀ» °ÈÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼ ÷´Ü ±â¼úÀÇ ±Þ¼ÓÇÑ Ã¤ÅÃÀº ÇâÈÄ ¸î ³â µ¿¾È ¼¼°è ¾È°ú¿ë ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.
ºÏ¹Ì°¡ ¼¼°è ½ÃÀåÀ» µ¶½Ä
Áö¿ªº°·Î´Â ºÏ¹Ì°¡ Àü ¼¼°è ¾È°ú¿ë ±â±â ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì ½ÃÀåÀÇ ¿ìÀ§´Â ÁÖ·Î ¼±ÁøÈµÈ ÀÇ·á ÀÎÇÁ¶ó, ³ôÀº ¾ÈÁúȯ À¯º´·ü, ÷´Ü ¾È°ú ±â¼ú µµÀÔ, ÀÇ·áºñ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ, ºÏ¹Ì°¡ ¼¼°è ½ÃÀå¿¡¼ ¼±µÎ¸¦ ´Þ¸®°í ÀÖ´Â µ¥¿¡´Â ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç¿Í Àß ±¸ÃàµÈ ÀÇ·á ½Ã½ºÅÛµµ ÇÑ ¸òÀ» Çϰí ÀÖ½À´Ï´Ù.
ÁöÁ¤ÇÐÀû ±äÀåÀÇ Áõ°¡°¡ ¼¼°è ¾È°ú¿ë ±â±â ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
ÁöÁ¤ÇÐÀû ±äÀåÀÌ °íÁ¶µÇ¸é¼ ¼¼°è ¾È°ú¿ë ±â±â ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¹«¿ª Á¦ÇѰú °ü¼¼´Â °ø±Þ¸Á¿¡ È¥¶õÀ» ¾ß±âÇϰí, »ý»ê ºñ¿ë Áõ°¡¿Í Çʼö ºÎǰÀÇ °ø±Þ Áö¿¬À¸·Î À̾îÁý´Ï´Ù. Á¦Á¶¾÷ü¿Í ÀÇ·á ¼ºñ½º Á¦°øÀÚ´Â Àç°í¸¦ À¯ÁöÇÏ°í ¼ö¿ä¿¡ ´ëÀÀÇÏ´Â µ¥ ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀ² º¯µ¿°ú ¿µÇâÀ» ¹Þ´Â Áö¿ªÀÇ °æÁ¦ ºÒ¾ÈÀº ¾È°ú¿ë ±â±âÀÇ °¡°Ý »ó½ÂÀ¸·Î À̾îÁ® ȯÀÚµéÀÇ Á¢±Ù¼ºÀ» ¶³¾î¶ß¸± ¼ö ÀÖ½À´Ï´Ù. °æÁ¦ÀÇ ºÒÈ®½Ç¼ºÀº R&D ÅõÀÚ¸¦ °¨¼Ò½ÃÄÑ ÀÌ ºÐ¾ßÀÇ ±â¼ú Çõ½ÅÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º¸°ÇÀÇ·á ¿¹»êÀÌ ´ç¸éÇÑ ÁöÁ¤ÇÐÀû À§±â¿¡ ´ëóÇϱâ À§ÇØ ÅõÀ﵃ ¼ö ÀÖÀ¸¸ç, ÀÌ´Â ¾È°ú ÀÇ·á¿¡ ´ëÇÑ ÀÚ±Ý °ø±Þ¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ÃÑüÀûÀ¸·Î ¼¼°è ¾È°ú¿ë ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ´Â º¯¼ö·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
°æÀï »óȲ
¼¼°è ¾È°ú¿ë ÀÇ·á±â±â ½ÃÀåÀº Ä¡¿ÇÑ °æÀïÀ» ¹úÀ̰í ÀÖÀ¸¸ç, ¸¹Àº ±â¾÷µéÀÌ ´õ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϱâ À§ÇØ °æÀïÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, EssilorLuxottica SA, HAAG-Streit Group, Hoya Corporation, Johnson and Johnson, Nidek Co.Ltd., Topcon Corporation, Ziemer Ophthalmological Systems AG, Volk Optical, Inc., Leica MicrosystemsÀÔ´Ï´Ù. ÀÌµé ±â¾÷Àº R&D ÅõÀÚ È®´ë, ÀμöÇÕº´, ÇÕÀÛÅõÀÚ, Á¦ÈÞ, ¶óÀ̼±½º °è¾à, ½ÅÁ¦Ç° ¹× ¼ºñ½º Ãâ½Ã µî ´Ù¾çÇÑ Àü·«À» ÅëÇØ ¼¼°è ¾È°ú¿ë ±â±â ½ÃÀå¿¡¼ÀÇ ÀÔÁö¸¦ ´õ¿í °ÈÇϰí ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ¼¼°è ¾È°ú¿ë ±â±â ½ÃÀåÀÇ ¼ºÀå ÀáÀç·Â, ÇâÈÄ µ¿Çâ ¹× Åë°è¿¡ ´ëÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ½ÃÀå ±Ô¸ð ¿¹ÃøÀ» ÃËÁøÇÏ´Â ¿äÀεµ ´Ù·ç°í ÀÖ½À´Ï´Ù. º» º¸°í¼´Â ¼¼°è ¾È°ú¿ë ±â±â ½ÃÀåÀÇ ÃÖ±Ù ±â¼ú µ¿Çâ°ú ÀÇ»ç°áÁ¤ÀÚ°¡ ÀûÀýÇÑ Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ¾÷°è ÀλçÀÌÆ®¸¦ Á¦°øÇϱâ À§ÇØ ³ë·ÂÇÕ´Ï´Ù. ¶ÇÇÑ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, µµÀü °úÁ¦, °æÀï·Â¿¡ ´ëÇØ¼µµ ºÐ¼®ÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ÇÁ·¹ÀÓ¿öÅ©
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ¼¼°èÀÇ ¾È°ú¿ë ±â±â ½ÃÀå ÀλçÀÌÆ®
- ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
- DROC ºÐ¼®
- ¼ºÀå ÃËÁø¿äÀÎ
- ¾ÈÁúȯ ¹× ½Ã·ÂÀå¾Ö Áõ°¡
- ¾È°ú¿ë ±â±âÀÇ ±â¼úÀû Áøº¸
- °í·ÉÈ Àα¸ Áõ°¡¿Í ±×¿¡ µû¸¥ ¾ÈÁúȯ
- ÷´Ü ¾È°ú Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀÎÁöµµ¿Í ä¿ë »ó½Â
- ¼ºÀå ¾ïÁ¦¿äÀÎ
- ¾È°ú¿ë ±â±âÀÇ °íºñ¿ë
- ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
- °³¹ßµµ»ó Áö¿ªÀÇ ¾È°ú ÀÇ·á ¼ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼º ºÎÁ·
- »óȯ °úÁ¦
- ±âȸ
- ÀáÀç·Â ÀÖ´Â ½ÅÈï ½ÃÀå
- ¿¹¹æÀû ¾È°ú Äɾ ´ëÇÑ ÁÖ¸ñÀÌ ³ô¾ÆÁø´Ù
- ÃÖ¼Òħ½À ¼ö¼ú ±â¼úÀÇ Áøº¸
- ¾È°ú¿ë ±â±â·ÎÀÇ µðÁöÅÐ ±â¼úÀÇ ÅëÇÕ
- °úÁ¦
- ´ëü Ä¡·á ¿É¼Ç°úÀÇ °æÀï
- ¼÷·ÃµÈ ¾È°úÀÇ¿Í ¾È°ú ÀÇ·á Àü¹®°¡ÀÇ ºÎÁ·
- ±â¼úÀÇ Áøº¸/ÃÖ±ÙÀÇ µ¿Çâ
- ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
- Porter's Five Forces ºÐ¼®
Á¦4Àå ¼¼°èÀÇ ¾È°ú¿ë ±â±â ½ÃÀå ¸¶ÄÉÆÃ Àü·«
Á¦5Àå ¼¼°èÀÇ ¾È°ú¿ë ±â±â ½ÃÀå : Áö¿ª ºÐ¼®
- ¼¼°èÀÇ ¾È°ú¿ë ±â±â ½ÃÀå, Áö¿ª ºÐ¼®, 2023³â
- ¼¼°èÀÇ ¾È°ú¿ë ±â±â ½ÃÀå, ½ÃÀå ¸Å·Â ºÐ¼®, 2024-2030³â
Á¦6Àå ¼¼°èÀÇ ¾È°ú¿ë ±â±â ½ÃÀå °³¿ä
- ½ÃÀå ±â±â¿Í ¿¹Ãø, 2019-2030
- ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
- ±â±âº°
- ¿Ü°ú¿ë ±â±â
- ³ì³»Àå ¹è¾× ±â±â
- ³ì³»Àå ½ºÅÙÆ®¿Í ÀÓÇöõÆ®
- ¾È³» ·»Áî ·¹ÀÌÀú
- ±âŸ
- Áø´Ü ¹× ¸ð´ÏÅ͸µ ±â±â
- ÀÚµ¿±¼Àý°Ë»ç±â¿Í °¢¸·°è
- °¢¸· ÅäÆ÷±×·¡ÇÇ ½Ã½ºÅÛ
- ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó Áø´Ü ½Ã½ºÅÛ
- °Ë¾È°æ
- ±¤°£¼·´ÜÃþÃÔ¿µ Àåºñ
- ±âŸ
- ½Ã·Â ±³Á¤ ±â±â
- ¾È°æ
- ÄÜÅÃÆ®·»Áî
- ÃÖÁ¾»ç¿ëÀÚº°
- º´¿ø
- ¾È°ú Ŭ¸®´Ð
- ±âŸ(ÇмúÁ¶»ç±â°ü)
- Áö¿ªº°
- ºÏ¹Ì
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
- ¶óƾ¾Æ¸Þ¸®Ä«(LATAM)
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«)
Á¦7Àå ºÏ¹ÌÀÇ ¾È°ú¿ë ±â±â ½ÃÀå
- ½ÃÀå ±â±â¿Í ¿¹Ãø, 2019-2030
- ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
- ±â±âº°
- ÃÖÁ¾»ç¿ëÀÚº°
- ±¹°¡º°
Á¦8Àå À¯·´ÀÇ ¾È°ú¿ë ±â±â ½ÃÀå
- ½ÃÀå ±â±â¿Í ¿¹Ãø, 2019-2030
- ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
- ±â±âº°
- ÃÖÁ¾»ç¿ëÀÚº°
- ±¹°¡º°
- µ¶ÀÏ
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ÇÁ¶û½º
- ½ºÆäÀÎ
- º§±â¿¡
- ·¯½Ã¾Æ
- ³×´ú¶õµå
- ±âŸ À¯·´
Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾È°ú¿ë ±â±â ½ÃÀå
- ½ÃÀå ±â±â¿Í ¿¹Ãø, 2019-2030
- ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
- ±â±âº°
- ÃÖÁ¾»ç¿ëÀÚº°
- ±¹°¡º°
- Áß±¹
- Àεµ
- ÀϺ»
- Çѱ¹
- È£ÁÖ¿Í ´ºÁú·£µå
- Àεµ³×½Ã¾Æ
- ¸»·¹À̽þÆ
- ½Ì°¡Æ÷¸£
- º£Æ®³²
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ¾È°ú¿ë ±â±â ½ÃÀå
- ½ÃÀå ±â±â¿Í ¿¹Ãø, 2019-2030
- ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
- ±â±âº°
- ÃÖÁ¾»ç¿ëÀÚº°
- ±¹°¡º°
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ¾Æ¸£ÇîÆ¼³ª
- Æä·ç
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾È°ú¿ë ±â±â ½ÃÀå
- ½ÃÀå ±â±â¿Í ¿¹Ãø, 2019-2030
- ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
- ±â±âº°
- ÃÖÁ¾»ç¿ëÀÚº°
- ±¹°¡º°
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- īŸ¸£
- Äí¿þÀÌÆ®
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- ³ªÀÌÁö¸®¾Æ
- ¾ËÁ¦¸®
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦12Àå °æÀï »óȲ
- ÁÖ¿ä ±â¾÷°ú ±× Á¦°ø ³»¿ë ¸®½ºÆ®
- 2023³â ¼¼°è ¾È°ú¿ë ±â±â ½ÃÀå Á¡À¯À² ºÐ¼®
- °æ¿µ ÆÄ¶ó¹ÌÅÍ¿¡ ÀÇÇÑ °æÀï º¥Ä¡¸¶Å·
- ÁÖ¿ä Àü·«Àû Àü°³(ÇÕº´, Àμö, Á¦ÈÞ µî)
Á¦13Àå ÁöÁ¤ÇÐÀû ±äÀå »ó½ÂÀÌ ¼¼°èÀÇ ¾È°ú¿ë ±â±â ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
Á¦14Àå ±â¾÷ °³¿ä(±â¾÷ °³¿ä, À繫 ¸ÅÆ®¸¯½º, °æÀï »óȲ, ÁÖ¿ä Àι°, ÁÖ¿ä °æÀï, ¿¬¶ôó, Àü·« Àü¸Á, SWOT ºÐ¼®)
- Alcon Inc.
- Bausch Health Companies Inc.
- Carl Zeiss Meditec AG
- EssilorLuxottica SA
- HAAG-Streit Group
- Hoya Corporation
- Johnson and Johnson
- Nidek Co. Ltd
- Topcon Corporation
- Ziemer Ophthalmic Systems AG
- Volk Optical, Inc.
- Leica Microsystems
- ±âŸ ÁÖ¿ä ±â¾÷
Á¦15Àå ÁÖ¿ä Àü·«Àû Á¦¾È
Á¦16Àå Á¶»ç ¹æ¹ý
ksm
¿µ¹® ¸ñÂ÷
Global Ophthalmological Devices Market Size Expanding to Reach Value of USD 57 Billion by 2030
Global Ophthalmological Devices Market is flourishing due to the growing prevalence of eye diseases, the rapidly aging population, rising awareness about eye health, and an increasing demand for minimally invasive surgical procedures.
BlueWeave Consulting, a leading strategic consulting and Market research firm, in its recent study, estimated Global Ophthalmological Devices Market size by value at USD 41.2 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Ophthalmological Devices Market size to expand at a CAGR of 4.80% reaching a value of USD 57 billion in 2030. Technological advancements, rising demand for the devices from emerging economies, and increasing awareness about eye health are major growth factors for Global Ophthalmological Devices Market. Rising disposable income and improved healthcare infrastructure in developing countries create growth opportunities for the market players. Key strategies include new product launches, expansion, acquisitions, partnerships, and cell-based treatments. Advancements in eye surgery, such as phacoemulsification and laser-assisted procedures, have improved treatment efficacy and vision prevention.
Opportunity - Growing adoption of innovative technologies
The Ophthalmological Devices Market across the globe is expected to grow due to advancements in nerve transplant treatments, bioengineered Corneas, artificial corneas, retinal implants, dry eye syndrome detection, intraocular lenses, contact lenses, and lasers. Wearable AR and VR goggles, AI-based therapies, and biosensors could also enhance eye tests and monitoring. Hence, rapid adoption of advanced technologies could boost the growth of Global Ophthalmological Devices Market in the coming years.
North America Region Dominates the Global Market
North America dominates Global Ophthalmological Devices Market by region. The market dominance of North America is primarly driven by advanced healthcare infrastructure, a high prevalence of eye disorders, significant adoption of advanced ophthalmological technologies, and increasing healthcare expenditure. The presence of major market players and a well-established healthcare system also contribute to North America's leadership position in the global market.
Impact of Escalating Geopolitical Tensions on Global Ophthalmological Devices Market
Escalating geopolitical tensions significantly impact Global Ophthalmological Devices Market. Trade restrictions and tariffs disrupt the supply chain, leading to increased production costs and delayed delivery of essential components. It creates challenges for manufacturers and healthcare providers in maintaining inventory and meeting demand. Additionally, fluctuating exchange rates and economic instability in affected regions can result in higher prices for ophthalmological devices, reducing accessibility for patients. Investment in research and development may decline due to economic uncertainties, stalling innovations in the field. Furthermore, healthcare budgets might be redirected to address immediate geopolitical crises, impacting funding for ophthalmological care. These factors collectively contribute to volatility and may hinder the growth of Global Ophthalmological Devices Market.
Competitive Landscape
Global Ophthalmological Devices Market is fiercely competitive, with numerous companies vying for a larger market share. Major companies in the market include Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, EssilorLuxottica SA, HAAG-Streit Group, Hoya Corporation, Johnson and Johnson, Nidek Co. Ltd, Topcon Corporation, Ziemer Ophthalmological Systems AG, Volk Optical, Inc., and Leica Microsystems. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Global Ophthalmological Devices Market.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Ophthalmological Devices Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Global Ophthalmological Devices Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the Market.
Table of Contents
1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
2. Executive Summary
3. Global Ophthalmic Devices Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.1.1. Increasing prevalence of eye disorders and vision impairment
- 3.2.1.2. Technological advancements in ophthalmic devices
- 3.2.1.3. Growing geriatric population and associated eye conditions
- 3.2.1.4. Rising awareness and adoption of advanced eye care solutions
- 3.2.2. Restraints
- 3.2.2.1. High cost of ophthalmic devices
- 3.2.2.2. Stringent regulatory framework
- 3.2.2.3. Lack of access to eye care services in developing regions
- 3.2.2.4. Reimbursement challenges
- 3.2.3. Opportunities
- 3.2.3.1. Emerging markets with untapped potential
- 3.2.3.2. Increasing focus on preventive eye care
- 3.2.3.3. Advancements in minimally invasive surgical techniques
- 3.2.3.4. Integration of digital technologies in ophthalmic devices
- 3.2.4. Challenges
- 3.2.4.1. Competition from alternative treatment options
- 3.2.4.2. Shortage of skilled ophthalmologists and eye care professionals
- 3.3. Technological Advancements/Recent Developments
- 3.4. Regulatory Framework
- 3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry
4. Global Ophthalmic Devices Market Marketing Strategies
5. Global Ophthalmic Devices Market: Geographical Analysis
- 5.1. Global Ophthalmic Devices Market, Geographical Analysis, 2023
- 5.2. Global Ophthalmic Devices Market, Market Attractiveness Analysis, 2024-2030
6. Global Ophthalmic Devices Market Overview
- 6.1. Market Devices & Forecast, 2019-2030
- 6.1.1. By Value (USD Billion)
- 6.2. Market Share and Forecast
- 6.2.1. By Devices
- 6.2.1.1. Surgical Devices
- 6.2.1.1.1. Glaucoma Drainage Devices
- 6.2.1.1.2. Glaucoma Stents and Implants
- 6.2.1.1.3. Intraocular Lenses Lasers
- 6.2.1.1.4. Others
- 6.2.1.2. Diagnostic and Monitoring Devices
- 6.2.1.2.1. Autorefractors and Keratometers
- 6.2.1.2.2. Corneal Topography Systems
- 6.2.1.2.3. Ophthalmic Ultrasound Imaging Systems
- 6.2.1.2.4. Ophthalmoscopes
- 6.2.1.2.5. Optical Coherence Tomography Scanners
- 6.2.1.2.6. Others
- 6.2.1.3. Vision Correction Devices
- 6.2.1.3.1. Spectacles
- 6.2.1.3.2. Contact Lenses
- 6.2.2. By End User
- 6.2.2.1. Hospitals
- 6.2.2.2. Ophthalmic Clinics
- 6.2.2.3. Others (Academic & Research Laboratories)
- 6.2.3. By Region
- 6.2.3.1. North America
- 6.2.3.2. Europe
- 6.2.3.3. Asia Pacific (APAC)
- 6.2.3.4. Latin America (LATAM)
- 6.2.3.5. Middle East and Africa (MEA)
7. North America Ophthalmic Devices Market
- 7.1. Market Devices & Forecast, 2019-2030
- 7.1.1. By Value (USD Billion)
- 7.2. Market Share & Forecast
- 7.2.1. By Devices
- 7.2.2. By End User
- 7.2.3. By Country
- 7.2.3.1. United States
- 7.2.3.1.1. By Devices
- 7.2.3.1.2. By End User
- 7.2.3.2. Canada
- 7.2.3.2.1. By Devices
- 7.2.3.2.2. By End User
8. Europe Ophthalmic Devices Market
- 8.1. Market Devices & Forecast, 2019-2030
- 8.1.1. By Value (USD Billion)
- 8.2. Market Share & Forecast
- 8.2.1. By Devices
- 8.2.2. By End User
- 8.2.3. By Country
- 8.2.3.1. Germany
- 8.2.3.1.1. By Devices
- 8.2.3.1.2. By End User
- 8.2.3.2. United Kingdom
- 8.2.3.2.1. By Devices
- 8.2.3.2.2. By End User
- 8.2.3.3. Italy
- 8.2.3.3.1. By Devices
- 8.2.3.3.2. By End User
- 8.2.3.4. France
- 8.2.3.4.1. By Devices
- 8.2.3.4.2. By End User
- 8.2.3.5. Spain
- 8.2.3.5.1. By Devices
- 8.2.3.5.2. By End User
- 8.2.3.6. Belgium
- 8.2.3.6.1. By Devices
- 8.2.3.6.2. By End User
- 8.2.3.7. Russia
- 8.2.3.7.1. By Devices
- 8.2.3.7.2. By End User
- 8.2.3.8. The Netherlands
- 8.2.3.8.1. By Devices
- 8.2.3.8.2. By End User
- 8.2.3.9. Rest of Europe
- 8.2.3.9.1. By Devices
- 8.2.3.9.2. By End User
9. Asia Pacific Ophthalmic Devices Market
- 9.1. Market Devices & Forecast, 2019-2030
- 9.1.1. By Value (USD Billion)
- 9.2. Market Share & Forecast
- 9.2.1. By Devices
- 9.2.2. By End User
- 9.2.3. By Country
- 9.2.3.1. China
- 9.2.3.1.1. By Devices
- 9.2.3.1.2. By End User
- 9.2.3.2. India
- 9.2.3.2.1. By Devices
- 9.2.3.2.2. By End User
- 9.2.3.3. Japan
- 9.2.3.3.1. By Devices
- 9.2.3.3.2. By End User
- 9.2.3.4. South Korea
- 9.2.3.4.1. By Devices
- 9.2.3.4.2. By End User
- 9.2.3.5. Australia & New Zealand
- 9.2.3.5.1. By Devices
- 9.2.3.5.2. By End User
- 9.2.3.6. Indonesia
- 9.2.3.6.1. By Devices
- 9.2.3.6.2. By End User
- 9.2.3.7. Malaysia
- 9.2.3.7.1. By Devices
- 9.2.3.7.2. By End User
- 9.2.3.8. Singapore
- 9.2.3.8.1. By Devices
- 9.2.3.8.2. By End User
- 9.2.3.9. Vietnam
- 9.2.3.9.1. By Devices
- 9.2.3.9.2. By End User
- 9.2.3.10. Rest of APAC
- 9.2.3.10.1. By Devices
- 9.2.3.10.2. By End User
10. Latin America Ophthalmic Devices Market
- 10.1. Market Devices & Forecast, 2019-2030
- 10.1.1. By Value (USD Billion)
- 10.2. Market Share & Forecast
- 10.2.1. By Devices
- 10.2.2. By End User
- 10.2.3. By Country
- 10.2.3.1. Brazil
- 10.2.3.1.1. By Devices
- 10.2.3.1.2. By End User
- 10.2.3.2. Mexico
- 10.2.3.2.1. By Devices
- 10.2.3.2.2. By End User
- 10.2.3.3. Argentina
- 10.2.3.3.1. By Devices
- 10.2.3.3.2. By End User
- 10.2.3.4. Peru
- 10.2.3.4.1. By Devices
- 10.2.3.4.2. By End User
- 10.2.3.5. Rest of LATAM
- 10.2.3.5.1. By Devices
- 10.2.3.5.2. By End User
11. Middle East & Africa Ophthalmic Devices Market
- 11.1. Market Devices & Forecast, 2019-2030
- 11.1.1. By Value (USD Billion)
- 11.2. Market Share & Forecast
- 11.2.1. By Devices
- 11.2.2. By End User
- 11.2.3. By Country
- 11.2.3.1. Saudi Arabia
- 11.2.3.1.1. By Devices
- 11.2.3.1.2. By End User
- 11.2.3.2. UAE
- 11.2.3.2.1. By Devices
- 11.2.3.2.2. By End User
- 11.2.3.3. Qatar
- 11.2.3.3.1. By Devices
- 11.2.3.3.2. By End User
- 11.2.3.4. Kuwait
- 11.2.3.4.1. By Devices
- 11.2.3.4.2. By End User
- 11.2.3.5. South Africa
- 11.2.3.5.1. By Devices
- 11.2.3.5.2. By End User
- 11.2.3.6. Nigeria
- 11.2.3.6.1. By Devices
- 11.2.3.6.2. By End User
- 11.2.3.7. Algeria
- 11.2.3.7.1. By Devices
- 11.2.3.7.2. By End User
- 11.2.3.8. Rest of MEA
- 11.2.3.8.1. By Devices
- 11.2.3.8.2. By End User
12. Competitive Landscape
- 12.1. List of Key Players and Their Offerings
- 12.2. Global Ophthalmic Devices Market Share Analysis, 2023
- 12.3. Competitive Benchmarking, By Operating Parameters
- 12.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
13. Impact of Escalating Geopolitical Tensions on Global Ophthalmic Devices Market
14. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- 14.1. Alcon Inc.
- 14.2. Bausch Health Companies Inc.
- 14.3. Carl Zeiss Meditec AG
- 14.4. EssilorLuxottica SA
- 14.5. HAAG-Streit Group
- 14.6. Hoya Corporation
- 14.7. Johnson and Johnson
- 14.8. Nidek Co. Ltd
- 14.9. Topcon Corporation
- 14.10. Ziemer Ophthalmic Systems AG
- 14.11. Volk Optical, Inc.
- 14.12. Leica Microsystems
- 14.13. Other Prominent Players
15. Key Strategic Recommendations
16. Research Methodology
- 16.1. Qualitative Research
- 16.1.1. Primary & Secondary Research
- 16.2. Quantitative Research
- 16.3. Market Breakdown & Data Triangulation
- 16.3.1. Secondary Research
- 16.3.2. Primary Research
- 16.4. Breakdown of Primary Research Respondents, By Region
- 16.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
°ü·ÃÀÚ·á